Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with Radiation and Temozolomide in Newly Diagnosed Glioblastoma
NCT00553150Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in glioblastoma (GBM), sponsored by Cancer and Leukemia Group B. Started Mar 2009; status: completed.
02
Drugs
everolimus
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT00553150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553150.